348 results on '"Moore, Martin L"'
Search Results
2. Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
3. Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy
4. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy
5. Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin
6. Minimally Invasive Sampling Method Identifies Differences in Taxonomic Richness of Nasal Microbiomes in Young Infants Associated with Mode of Delivery
7. Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells
8. Respiratory Syncytial Virus and Reactive Airway Disease
9. Influence of Respiratory Syncytial Virus Strain Differences on Pathogenesis and Immunity
10. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma
11. An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
12. Cyclooxygenase inhibition abrogates aeroallergen-induced immune tolerance by suppressing prostaglandin I2 receptor signaling
13. Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors
14. BAC-Based Recovery of Recombinant Respiratory Syncytial Virus (RSV)
15. Using urine metabolomics to understand the pathogenesis of infant respiratory syncytial virus (RSV) infection and its role in childhood wheezing
16. ERRATUM: Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
17. Reverse Genetics of Respiratory Syncytial Virus
18. Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
19. Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk
20. RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice.
21. Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease
22. Toward Primary Prevention of Asthma. Reviewing the Evidence for Early-Life Respiratory Viral Infections as Modifiable Risk Factors to Prevent Childhood Asthma
23. One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
24. Early infection with repiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma
25. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins
26. Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease
27. A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion
28. The intersection of respiratory syncytial virus infection, innate immunity and allergic lung disease
29. Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think
30. The Design of Vaccines Based on the Shielding of Antigenic Site Ø of a Respiratory Syncytial Virus Fusion Protein Immunogen
31. A Mechanistic Advance in Understanding RSV Pathogenesis, but Still a Long Way from Therapy
32. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics
33. An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice
34. Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles
35. Evaluation of the role of respiratory syncytial virus surface glycoproteins F and G on viral stability and replication: implications for future vaccine design
36. Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform
37. The Design of Vaccines Based on the Shielding of Antigenic Site Ø of a Respiratory Syncytial Virus Fusion Protein Immunogen.
38. Nasopharyngeal Lactobacillus is associated with a reduced risk of childhood wheezing illnesses following acute respiratory syncytial virus infection in infancy
39. Infant Viral Respiratory Infection Nasal Immune-Response Patterns and Their Association with Subsequent Childhood Recurrent Wheeze
40. Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses
41. Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus–induced type 2 responses and immunopathology
42. Polyvalent vaccines: High-maintenance heroes
43. Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues
44. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins
45. Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine
46. Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy
47. Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
48. STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection
49. Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses
50. Glucagon-like peptide-1 receptor signaling attenuates RSV-induced type 2 responses and immunopathology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.